The antisignaling agent SC-ααδ9, 4-(benzyl-(2-[(2,5- diphenyloxazole-4-carbonyl)amino]ethyl)carbamoyl)-2-decanoylaminobutyric acid, is a structurally unique phospholipid analogue with phospholipase C inhibitory activity

Molecular Cancer Therapeutics

Volumn 1, Issue 11, 2002, Pages 885-892

  Vogt, Andreas ^a   Pestell, Katharine E ^a   Day, Billy W ^b   Lazo, John S ^a   Wipf, Peter ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BRIDGED COMPOUND; ENZYME INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE; OXAZOLE DERIVATIVE; PHOSPHOLIPASE C; PHOSPHOLIPASE D; PHOSPHOLIPID; SC ALPHAALPHADELTA9; SC-ALPHAALPHADELTA9; THIOKETONE; TRICYCLODECANE 9 YL XANTHOGENATE; TRICYCLODECANE-9-YL-XANTHOGENATE;

ANIMAL; ARTICLE; CELL DIVISION; CELL MOTION; CELL SURVIVAL; CHEMICAL MODEL; CHEMICAL STRUCTURE; CHEMISTRY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; ENZYME ACTIVATION; FIBROBLAST; GENETICS; IC 50; METABOLISM; ONCOGENE RAS; RAT; SIGNAL TRANSDUCTION; TIME; WESTERN BLOTTING; WOUND HEALING;

ALKALINE PHOSPHATASE; ANIMALS; BLOTTING, WESTERN; BRIDGED COMPOUNDS; CELL DIVISION; CELL MOVEMENT; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; ENZYME INHIBITORS; FIBROBLASTS; GENES, RAS; INHIBITORY CONCENTRATION 50; MITOGEN-ACTIVATED PROTEIN KINASES; MODELS, CHEMICAL; MODELS, MOLECULAR; OXAZOLES; PHOSPHOLIPASE C; PHOSPHOLIPASE D; PHOSPHOLIPIDS; RATS; SIGNAL TRANSDUCTION; THIONES; TIME FACTORS; WOUND HEALING;

EID: 0036725526     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Wipf, P., Cunningham, A., Rice, R. L., and Lazo, J. S. Combinatorial synthesis and biological evaluation of library of small-molecule Ser/Thr-protein phosphatase inhibitors. Bioorg. Med. Chem., 5: 165-177, 1997. (Pubitemid 27065360)
2. Vogt, A., Wang, A. S., Johnson, C. S., Fabisiak, J. P., Wipf, P., and Lazo, J. S. In vivo antitumor activity and induction of insulin-like growth factor-1-resistant apoptosis by SC-ααδ9. J. Pharmacol. Exp. Ther., 292: 530-537, 2000. (Pubitemid 30067415)
3. Tamura, K., Rice, R. L., Wipf, P., and Lazo, J. S. Dual G1 and G2-M phase inhibition by SC-ααδ9, a combinatorially derived Cdc25 phosphatase inhibitor. Oncogene, 18: 6989-6996, 1999. (Pubitemid 30028868)
4. Vogt, A., Rice, R. L., Settineri, C. E., Yokokawa, F., Yokokawa, S., Wipf, P., and Lazo, J. S. Disruption of insulin-like growth factor-1 signaling and down-regulation of cdc2 by SC-ααδ9, a novel small molecule antisignaling agent identified in a targeted array library. J. Pharmacol. Exp. Ther., 287: 806-813, 1998. (Pubitemid 29133686)
5. Kozma, S. C., Bogaard, M. E., Buser, K., Saurer, S. M., Bos, J. L., Groner, B., and Hynes, N. E. The human c-Kirsten ras gene is activated by a novel mutation in codon 13 in the breast carcinoma cell line MDA-MB231. Nucleic Acids Res., 15: 5963-5971, 1987.
6. Lacal, J. C., Moscat, J., and Aaronson, S. A. Novel source of 1,2-diacylglycerol elevated in cells transformed by Ha-ras oncogene. Nature, 330: 269-272, 1987. (Pubitemid 18006423)
7. Johansen, T., Bjorkoy, G., Overvatn, A., Diaz-Meco, M. T., Traavik, T., and Moscat, J. NIH 3T3 cells stably transfected with the gene encoding phosphatidylcholine-hydrolyzing phospholipase C from Bacillus cereus acquire a transformed phenotype. Mol. Cell. Biol., 14: 646-654, 1994.
8. Chang, J. S., Noh, D. Y., Park, I. A., Kim, M. J., Song, H., Ryu, S. H., and Suh, P. G. Overexpression of phospholipase C-γ1 in rat 3Y1 fibroblast cells leads to malignant transformation. Cancer Res., 57: 5465-5468, 1997. (Pubitemid 28006748)
9. Cai, H., Erhardt, P., Troppmair, J., Diaz-Meco, M. T., Sithanandam, G., Rapp, U. R., Moscat, J., and Cooper, G. M. Hydrolysis of phosphatidylcholine couples Ras to activation of Raf protein kinase during mitogenic signal transduction. Mol. Cell. Biol., 13: 7645-7651, 1993. (Pubitemid 23354289)
10. Arteaga, C. L., Johnson, M. D., Todderud, G., Coffey, R. J., Carpenter, G., and Page, D. L. Elevated content of the tyrosine kinase substrate phospholipase C-γ1 in primary human breast carcinomas. Proc. Natl. Acad. Sci. USA, 88: 10435-10439, 1991. (Pubitemid 21915850)
11. Noh, D. Y., Kang, H. S., Kim, Y. C., Youn, Y. K., Oh, S. K., Choe, K. J., Park, I. A., Ryu, S. H., and Suh, P. G. Expression of phospholipase C-γ1 and its transcriptional regulators in breast cancer tissues. Anticancer Res, 18: 2643-2648, 1998. (Pubitemid 28386561)
12. Noh, D. Y., Lee, Y. H., Kim, S. S., Kim, Y. I., Ryu, S. H., Suh, P. G., and Park, J. G. Elevated content of phospholipase C-γ1 in colorectal cancer tissues. Cancer, 73: 36-41, 1994.
13. Zhao, Y., Ehara, H., Akao, Y., Shamoto, M., Nakagawa, Y., Banno, Y., Deguchi, T., Ohishi, N., Yagi, K., and Nozawa, Y. Increased activity and intranuclear expression of phospholipase D2 in human renal cancer. Biochem. Biophys. Res. Commun., 278: 140-143, 2000.
14. Uchida, N., Okamura, S., and Kuwano, H. Phospholipase D activity in human gastric carcinoma. Anticancer Res., 19: 671-675, 1999. (Pubitemid 29168314)
15. Carnero, A., Cuadrado, A., del Peso, L., and Lacal, J. C. Activation of type D phospholipase by serum stimulation and ras-induced transformation in NIH3T3 cells. Oncogene, 9: 1387-1395, 1994. (Pubitemid 24123656)
16. Lu, Z., Hornia, A., Joseph, T., Sukezane, T., Frankel, P., Zhong, M., Bychenok, S., Xu, L., Feig, L. A., and Foster, D. A. Phospholipase D and RalA cooperate with the epidermal growth factor receptor to transform 3Y1 rat fibroblasts. Mol. Cell. Biol., 20: 462-467, 2000. (Pubitemid 30023087)
17. Min, D. S., Kwon, T. K., Park, W. S., Chang, J. S., Park, S. K., Ahn, B. H., Ryoo, Z. Y., Lee, Y. H., Lee, Y. S., Rhie, D. J., Yoon, S. H., Hahn, S. J., Kim, M. S., and Jo, Y. H. Neoplastic transformation and tumorigenesis associated with overexpression of phospholipase D isozymes in cultured murine fibroblasts. Carcinogenesis, 22: 1641-1647, 2001. (Pubitemid 32952141)
18. Schutze, S., Potthoff, K., Machleidt, T., Berkovic, D., Wiegmann, K., and Kronke, M. TNF activates NF-κB by phosphatidylcholine-specific phospholipase C-induced "acidic" sphingomyelin breakdown. Cell, 71: 765-776, 1992.
19. Xie, W., Peng, H., Zalkow, L. H., Li, Y. H., Zhu, C., Powis, G., and Kunkel, M. 3[β]-Hydroxy-6-aza-cholestane and related analogues as phosphatidylinositol specific phospholipase C (PI-PLC) inhibitors with antitumor activity. Bioorg. Med. Chem., 8: 699-706, 2000. (Pubitemid 30177200)
20. Hill, S. R., Bonjouklian, R., Powis, G., Abraham, R. T., Ashendel, C. L., and Zalkow, L. H. A multisample assay for inhibitors of phosphatidylinositol phospholipase C: identification of naturally occurring peptide inhibitors with antiproliferative activity. Anticancer Drug Des., 9: 353-361, 1994. (Pubitemid 24297531)
21. Rice, R. L., Rusnak, J. M., Yokokawa, F., Yokokawa, S., Messner, D. J., Boynton, A. L., Wipf, P., and Lazo, J. S. A targeted library of small-molecule, tyrosine, and dual-specificity phosphatase inhibitors derived from a rational core design and random side chain variation. Biochemistry, 36: 15965-15974, 1997. (Pubitemid 28027401)
22. Clayton, G. M., Peak-Chew, S. Y., Evans, R. M., and Schwabe, J. W. The structure of the ultraspiracle ligand-binding domain reveals a nuclear receptor locked in an inactive conformation. Proc. Natl. Acad. Sci. USA, 98: 1549-1554, 2001. (Pubitemid 32165536)
23. Der, C. J., Finkel, T., and Cooper, G. M. Biological and biochemical properties of human rasH genes mutated at codon 61. Cell, 44: 167-176, 1986. (Pubitemid 16036724)
24. Garrigues, J., Anderson, J., Hellstrom, K. E., and Hellstrom, I. Anti-tumor antibody BR96 blocks cell migration and binds to a lysosomal membrane glycoprotein on cell surface microspikes and ruffled membranes. J. Cell Biol., 125: 129-142, 1994. (Pubitemid 24100044)
25. Fyfe, P. K., McAuley, K. E., Roszak, A. W., Isaacs, N. W., Cogdell, R. J., and Jones, M. R. Probing the interface between membrane proteins and membrane lipids by X-ray crystallography. Trends Biochem. Sci., 26: 106-112, 2001. (Pubitemid 32144745)
26. Milella, M., Gismondi, A., Roncaioli, P., Palmieri, G., Morrone, S., Piccoli, M., Frati, L., Cifone, M. G., and Santoni, A. β1 integrin crosslinking inhibits CD16-induced phospholipase D and secretory phospholipase A2 activity and granule exocytosis in human NK cells: role of phospholipase D in CD16-triggered degranulation. J. Immunol., 162: 2064-2072, 1999. (Pubitemid 29288826)
27. Kelley, G. G., Reks, S. E., Ondrako, J. M., and Smrcka, A. V. Phospholipase C(ε): a novel Ras effector. EMBO J., 20: 743-754, 2001.
28. Clark, M. A., Shorr, R. G., and Bomalaski, J. S. Antibodies prepared to Bacillus cereus phospholipase C crossreact with a phosphatidylcholine preferring phospholipase C in mammalian cells. Biochem. Biophys. Res. Commun., 140: 114-119, 1986.
29. Wooten, D. K., Teague, T. K., and McIntyre, B. W. Separation of integrin-dependent adhesion from morphological changes based on differential PLC specificities. J. Leukoc. Biol., 65: 127-136, 1999. (Pubitemid 29024926)
30. Shibayama, H., Anzai, N., Braun, S. E., Fukuda, S., Mantel, C., and Broxmeyer, H. E. H-Ras is involved in the inside-out signaling pathway of interleukin-3-induced integrin activation. Blood, 93: 1540-1548, 1999. (Pubitemid 29102481)
31. Kobayashi, E., Nakano, H., Morimoto, M., and Tamaoki, T. Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. Biochem. Biophys. Res. Commun., 159: 548-553, 1989. (Pubitemid 19089785)
32. Sciorra, V. A., Hammond, S. M., and Morris, A. J. Potent direct inhibition of mammalian phospholipase d isoenzymes by calphostin-c. Biochemistry, 40: 2640-2646, 2001. (Pubitemid 32171740)
33. Bjorkoy, G., Perander, M., Overvatn, A., and Johansen, T. Reversion of ras- and phosphatidylcholine-hydrolyzing phospholipase C-mediated transformation of NIH 3T3 cells by a dominant interfering mutant of protein kinase Cλ is accompanied by the loss of constitutive nuclear mitogen-activated protein kinase/extracellular signal-regulated kinase activity. J. Biol. Chem., 272: 11557-11565, 1997. (Pubitemid 27184167)
34. Vogt, A., Takahito, A., Ducruet, A. P., Chesebrough, J., Nemoto, K., Carr, B. I., and Lazo, J. S. Spatial analysis of key signaling proteins by high-content solid-phase cytometry in Hep3B cells treated with an inhibitor of Cdc25 dual-specificity phosphatases. J. Biol. Chem., 276: 20544-20550, 2001.
35. Turner, T., Epps-Fung, M. V., Kassis, J., and Wells, A. Molecular inhibition of phospholipase cγ signaling abrogates DU-145 prostate tumor cell invasion. Clin. Cancer Res., 3: 2275-2282, 1997. (Pubitemid 28133146)
36. Ji, Q. S., Winnier, G. E., Niswender, K. D., Horstman, D., Wisdom, R., Magnuson, M. A., and Carpenter, G. Essential role of the tyrosine kinase substrate phospholipase C-γ1 in mammalian growth and development. Proc. Natl. Acad. Sci. USA, 94: 2999-3003, 1997. (Pubitemid 27157253)
37. Takata, M., Homma, Y., and Kurosaki, T. Requirement of phospholipase C-γ 2 activation in surface immunoglobulin M-induced B cell apoptosis. J. Exp. Med., 182: 907-914, 1995.
38. Wang, S., Gebre-Medhin, S., Betsholtz, C., Stalberg, P., Zhou, Y., Larsson, C., Weber, G., Feinstein, R., Oberg, K., Gobl, A., and Skogseid, B. Targeted disruption of the mouse phospholipase C β3 gene results in early embryonic lethality. FEBS Lett., 441: 261-265, 1998. (Pubitemid 29027907)